These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25976666

  • 1. Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.
    Ismael S, Purushothaman S, Harikrishnan VS, Nair RR.
    Mol Cell Biochem; 2015 Aug; 406(1-2):173-82. PubMed ID: 25976666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolic Modulation by Medium-Chain Triglycerides Reduces Oxidative Stress and Ameliorates CD36-Mediated Cardiac Remodeling in Spontaneously Hypertensive Rat in the Initial and Established Stages of Hypertrophy.
    Saifudeen I, Subhadra L, Konnottil R, Nair RR.
    J Card Fail; 2017 Mar; 23(3):240-251. PubMed ID: 27530817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats].
    Chen HJ, Chen JZ, Wang XX, Yu M.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):470-6. PubMed ID: 17924466
    [Abstract] [Full Text] [Related]

  • 6. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
    Shimojo N, Miyauchi T, Iemitsu M, Irukayama-Tomobe Y, Maeda S, Ohkubo T, Tanaka Y, Goto K, Yamaguchi I.
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
    [Abstract] [Full Text] [Related]

  • 7. Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.
    Huang J, Xu L, Huang Q, Luo J, Liu P, Chen S, Yuan X, Lu Y, Wang P, Zhou S.
    J Cell Mol Med; 2015 Jul; 19(7):1672-88. PubMed ID: 25753319
    [Abstract] [Full Text] [Related]

  • 8. Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.
    Ismael S, Nair RR.
    Mol Cell Biochem; 2021 Jan; 476(1):483-491. PubMed ID: 33000353
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA, Cui L, Rude MK, Lebrasseur NK, Ngoy S, De Silva DS, Siwik DA, Liao R, Sam F.
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [Abstract] [Full Text] [Related]

  • 10. PPAR-α agonists acutely inhibit Ca2+-independent PLA2 to reduce H2O2-induced contractions in aortae of spontaneously hypertensive rats.
    Chen H, Man RYK, Leung SWS.
    Am J Physiol Heart Circ Physiol; 2018 Mar 01; 314(3):H681-H691. PubMed ID: 29127234
    [Abstract] [Full Text] [Related]

  • 11. Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.
    Castiglioni L, Pignieri A, Fiaschè M, Giudici M, Crestani M, Mitro N, Abbate M, Zoja C, Rottoli D, Foray C, Fiordaliso F, Guerrini U, Tremoli E, Sironi L, Gelosa P.
    J Hypertens; 2018 May 01; 36(5):1129-1146. PubMed ID: 29278547
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Liang F, Wang F, Zhang S, Gardner DG.
    Endocrinology; 2003 Sep 01; 144(9):4187-94. PubMed ID: 12933694
    [Abstract] [Full Text] [Related]

  • 13. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
    Engle SK, Solter PF, Credille KM, Bull CM, Adams S, Berna MJ, Schultze AE, Rothstein EC, Cockman MD, Pritt ML, Liu H, Lu Y, Chiang AY, Watson DE.
    Toxicol Sci; 2010 Apr 01; 114(2):183-92. PubMed ID: 20044590
    [Abstract] [Full Text] [Related]

  • 14. Effects and mechanisms of Fenofibrate on the secretion of vascular endothelial contraction factors in hypertensive rats.
    Zhu Y, Wang HS, Li XM, Qu C.
    Genet Mol Res; 2014 Jul 24; 13(3):5269-75. PubMed ID: 25078582
    [Abstract] [Full Text] [Related]

  • 15. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D, Bandyopadhyay A.
    Cell Physiol Biochem; 2018 Jul 24; 49(1):245-259. PubMed ID: 30138942
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C, Montessuit C, Papageorgiou I, Lerch R.
    Pflugers Arch; 2007 Dec 24; 455(3):443-54. PubMed ID: 17643263
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats.
    Shin SJ, Lim JH, Chung S, Youn DY, Chung HW, Kim HW, Lee JH, Chang YS, Park CW.
    Hypertens Res; 2009 Oct 24; 32(10):835-45. PubMed ID: 19644507
    [Abstract] [Full Text] [Related]

  • 20. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1481-8. PubMed ID: 15093887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.